796 Prevention of chemotherapy related anemia by recombinant human erythropoietin (EPO) in patients with small cell lung cancer (SCLC) receiving cyclophosphamide, doxorubicin, and etoposide (CAE) chemotherapy with G-SCF support
Authors:
- J. CrawfordJCJ. Crawford
- S. BlackwellSBS. Blackwell
- D. ShoemakerDSD. Shoemaker
- M.R. PupaMPM.R. Pupa
- T. MulhausenTMT. Mulhausen
- J. HerndonJHJ. Herndon
- E. WinerEWE. Winer
- J. FlynnJFJ. Flynn
- H. DempseyHDH. Dempsey
- 1 August 1997
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 18, 205